Primary Biliary Cholangitis (PBC) Assure

People with Primary Biliary Cholangitis (PBC) are asked to participate in a research study being conducted by North Shore University Hospital.

You may be eligible to participate in this study if you:

• Have given informed consent (signed and dated)
• Have participated in a PBC study with seladelpar
• Are a female of reproductive potential, you must use at least one barrier contraceptive and a second effective birth control method during the study

You may NOT participate in this study if you:

• Have use of an experimental or unapproved treatment for PBC within 3 months
• Have a known history of chronic viral hepatitis
• Have auto-immune hepatitis
• Have a history of malignancy diagnosed or treated, actively or within 2 years, or active
evaluation for malignancy
• Have had treatment with any other investigational therapy or medical device within 30 days
• Are pregnant or breastfeeding

Contact Information
Radica Palmer, Study Coordinator
400 Community Drive Manhasset, NY 11030
Phone: (516) 562-2082